{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,4]],"date-time":"2025-10-04T07:46:31Z","timestamp":1759563991594,"version":"3.37.3"},"reference-count":23,"publisher":"BMJ","issue":"11","content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["BMJ Open"],"accepted":{"date-parts":[[2019,10,25]]},"published-print":{"date-parts":[[2019,11]]},"abstract":"<jats:sec><jats:title>Objectives<\/jats:title><jats:p>To assess whether changes in patterns of combined oral contraceptive (COC) prescriptions to starters between 2008 and 2016 were in line with changes in national recommendations for use.<\/jats:p><\/jats:sec><jats:sec><jats:title>Design<\/jats:title><jats:p>Historical prospective cohort study.<\/jats:p><\/jats:sec><jats:sec><jats:title>Setting<\/jats:title><jats:p>The national Norwegian Prescription Database.<\/jats:p><\/jats:sec><jats:sec><jats:title>Participants<\/jats:title><jats:p>Women aged 10\u201349 years who started COCs between 1 January 2008 and 30 June 2016, in total 285 009 women.<\/jats:p><\/jats:sec><jats:sec><jats:title>Primary outcome<\/jats:title><jats:p>The proportion of levonorgestrel-containing COC prescriptions to starters.<\/jats:p><\/jats:sec><jats:sec><jats:title>Intervention<\/jats:title><jats:p>The Norwegian Medical Agency recommended levonorgestrel-containing COCs to starters from 2010 onwards.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>The proportion of levonorgestrel-containing COCs prescribed to starters increased from 41% in 2008 to 80% in 2016 with the greatest increase from 2011 to 2012. This prescription pattern comprised all age groups but was observed to a lower extent among older women. Public health nurses and midwifes had the highest compliance with recommendations and prescribed levonorgestrel-containing COCs to 96% of starters aged &lt;20 years in 2016, compared with 75% and 86% among general practitioners and doctors with no specialty.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>All professions have increased the proportion of levonorgestrel-containing COC prescriptions to starters. Public health nurses and midwives had the highest compliance with the new recommendations. Future studies will examine whether this shift in prescription pattern has prevented venous thromboembolism in women of reproductive age in Norway.<\/jats:p><\/jats:sec>","DOI":"10.1136\/bmjopen-2018-027888","type":"journal-article","created":{"date-parts":[[2019,11,26]],"date-time":"2019-11-26T17:55:21Z","timestamp":1574790921000},"page":"e027888","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":4,"title":["Do Norwegian providers comply with national recommendations when prescribing combined oral contraceptives to starters? A cohort study"],"prefix":"10.1136","volume":"9","author":[{"given":"Julie","family":"Ekman","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9875-4991","authenticated-orcid":false,"given":"Finn Egil","family":"Skjeldestad","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"239","published-online":{"date-parts":[[2019,11,26]]},"reference":[{"key":"2024052012210281000_9.11.e027888.1","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1002\/psb.1103","article-title":"Oral contraception: properties and side-effects of COCs and POPs","volume":"24","author":"MacGregor","year":"2013","journal-title":"Prescriber"},{"key":"2024052012210281000_9.11.e027888.2","doi-asserted-by":"publisher","DOI":"10.1016\/j.clinthera.2011.11.006"},{"key":"2024052012210281000_9.11.e027888.3","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.1016\/S0140-6736(80)91550-0","article-title":"Oral contraceptives and thromboembolic disease: effects of lowering \u0152strogen content","volume":"315","author":"B\u00f6ttiger","year":"1980","journal-title":"The Lancet"},{"key":"2024052012210281000_9.11.e027888.4","doi-asserted-by":"crossref","unstructured":"\u00d8 L , L\u00f8kkegaard E , Svendens AL , et al . Hormonal contraception and risk of venous thromboembolism: national follow-up study. BMJ 2009;339.","DOI":"10.1136\/bmj.b2890"},{"key":"2024052012210281000_9.11.e027888.5","doi-asserted-by":"crossref","unstructured":"Nielsen LH , Skovlund CW , \u00d8 L , et al . Risk of venous thromboembolism from use of oral contraceptives containing different progestogens and oestrogen doses: Danish cohort study, 2001-9. BMJ 2011;343.","DOI":"10.1136\/bmj.d6423"},{"key":"2024052012210281000_9.11.e027888.6","doi-asserted-by":"crossref","DOI":"10.1136\/bmj.b2921","article-title":"The venous thrombotic risk of oral contraceptives, effects of oestrogen dose and progestogen type: results of the MEGA case-control study","volume":"339","author":"van Hylckama Vlieg","year":"2009","journal-title":"BMJ"},{"key":"2024052012210281000_9.11.e027888.7","doi-asserted-by":"crossref","first-page":"1593","DOI":"10.1016\/S0140-6736(95)91929-5","article-title":"Enhancement by factor V Leiden mutation of risk of deep-vein thrombosis associated with oral contraceptives containing a third-generation progestagen","volume":"346","author":"Bloemenkamp","year":"1995","journal-title":"The Lancet"},{"key":"2024052012210281000_9.11.e027888.8","doi-asserted-by":"crossref","first-page":"1589","DOI":"10.1016\/S0140-6736(95)91928-7","article-title":"Risk of idiopathic cardiovascular death and rionfatal venous thromboembolism in women using oral contraceptives with differing progestagen components","volume":"346","author":"Jick","year":"1995","journal-title":"The Lancet"},{"key":"2024052012210281000_9.11.e027888.9","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(95)91136-7"},{"key":"2024052012210281000_9.11.e027888.10","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.321.7270.1190"},{"key":"2024052012210281000_9.11.e027888.11","doi-asserted-by":"crossref","DOI":"10.1136\/bmj.d2151","article-title":"Risk of non-fatal venous thromboembolism in women using oral contraceptives containing drospirenone compared with women using oral contraceptives containing levonorgestrel: case-control study using United States claims data","volume":"342","author":"Jick","year":"2011","journal-title":"BMJ"},{"key":"2024052012210281000_9.11.e027888.12","doi-asserted-by":"publisher","DOI":"10.1016\/S0010-7824(01)00307-9"},{"key":"2024052012210281000_9.11.e027888.13","doi-asserted-by":"crossref","DOI":"10.1136\/bmj.d2139","article-title":"Risk of venous thromboembolism in users of oral contraceptives containing drospirenone or levonorgestrel: nested case-control study based on UK general practice research database","volume":"342","author":"Parkin","year":"2011","journal-title":"BMJ"},{"key":"2024052012210281000_9.11.e027888.14","doi-asserted-by":"crossref","DOI":"10.1136\/bmj.h2135","article-title":"Use of combined oral contraceptives and risk of venous thromboembolism: nested case-control studies using the QResearch and CPRD databases","volume":"350","author":"Vinogradova","year":"2015","journal-title":"BMJ"},{"key":"2024052012210281000_9.11.e027888.15","unstructured":"Benefits of combined hormonal contraceptives (CHCs) continue to outweigh risks - CHMP endorses PRAC recommendation: European medicines agency 2013. Available: Http:\/\/www.ema.europa.eu\/ema\/index.jsp?curl=pages\/news_and_events\/news\/2013\/11\/news_detail_001969.jsp&mid=WC0b01ac058004d5c1 [Accessed 25.10.2016]."},{"key":"2024052012210281000_9.11.e027888.16","doi-asserted-by":"publisher","DOI":"10.1016\/S0049-3848(09)70015-5"},{"key":"2024052012210281000_9.11.e027888.17","doi-asserted-by":"publisher","DOI":"10.1016\/S0010-7824(84)80006-2"},{"key":"2024052012210281000_9.11.e027888.18","doi-asserted-by":"publisher","DOI":"10.1034\/j.1600-0412.2002.810603.x"},{"key":"2024052012210281000_9.11.e027888.19","doi-asserted-by":"publisher","DOI":"10.1111\/j.1538-7836.2012.04720.x"},{"key":"2024052012210281000_9.11.e027888.20","unstructured":"Referat fra m\u00f8te I bivirkningsnemnda 28. januar 2009: Statens legemiddelverk 2009. Available: Http:\/\/docplayer.me\/amp\/15563885-Referat-fra-mote-i-bivirkningsnemnda-28-januar-2009.html [Accessed 5 May 2018]."},{"key":"2024052012210281000_9.11.e027888.21","first-page":"129","article-title":"Establishment of the nationwide Norwegian Prescription Database (NorPD) - new opportunities for research in pharmacoepidemiology in Norway","volume":"18","author":"Furu","year":"2008","journal-title":"Nor J Epidemiol"},{"key":"2024052012210281000_9.11.e027888.22","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.contraception.2015.03.016","article-title":"Pharmacy claims data versus patient self-report to measure contraceptive method continuation","volume":"92","author":"Triebwasser","year":"2015","journal-title":"Contraception"},{"key":"2024052012210281000_9.11.e027888.23","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1111\/aogs.13055","article-title":"Contraceptive use in the Nordic countries","volume":"96","author":"Lindh","year":"2017","journal-title":"Acta Obstet Gynecol Scand"}],"container-title":["BMJ Open"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/bmjopen-2018-027888","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,20]],"date-time":"2024-05-20T19:34:57Z","timestamp":1716233697000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmjopen.bmj.com\/lookup\/doi\/10.1136\/bmjopen-2018-027888"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,11]]},"references-count":23,"journal-issue":{"issue":"11","published-online":{"date-parts":[[2019,11,26]]},"published-print":{"date-parts":[[2019,11]]}},"alternative-id":["10.1136\/bmjopen-2018-027888"],"URL":"https:\/\/doi.org\/10.1136\/bmjopen-2018-027888","relation":{},"ISSN":["2044-6055","2044-6055"],"issn-type":[{"type":"print","value":"2044-6055"},{"type":"electronic","value":"2044-6055"}],"subject":[],"published":{"date-parts":[[2019,11]]}}}